• English

    Google Translate Disclaimer

    The Maryland Department of Information Technology (“DoIT”) offers translations of the content through Google Translate. Because Google Translate is an external website, DoIT does not control the quality or accuracy of translated content. All DoIT content is filtered through Google Translate which may result in unexpected and unpredictable degradation of portions of text, images and the general appearance on translated pages. Google Translate may maintain unique privacy and use policies. These policies are not controlled by DoIT and are not associated with DoIT’s privacy and use policies. After selecting a translation option, users will be notified that they are leaving DoIT’s website. Users should consult the original English content on DoIT’s website if there are any questions about the translated content.

    DoIT uses Google Translate to provide language translations of its content. Google Translate is a free, automated service that relies on data and technology to provide its translations. The Google Translate feature is provided for informational purposes only. Translations cannot be guaranteed as exact or without the inclusion of incorrect or inappropriate language. Google Translate is a third-party service and site users will be leaving DoIT to utilize translated content. As such, DoIT does not guarantee and does not accept responsibility for, the accuracy, reliability, or performance of this service nor the limitations provided by this service, such as the inability to translate specific files like PDFs and graphics (e.g. .jpgs, .gifs, etc.).

    DoIT provides Google Translate as an online tool for its users, but DoIT does not directly endorse the website or imply that it is the only solution available to users. All site visitors may choose to use alternate tools for their translation needs. Any individuals or parties that use DoIT content in translated form, whether by Google Translate or by any other translation services, do so at their own risk. DoIT is not liable for any loss or damages arising out of, or issues related to, the use of or reliance on translated content. DoIT assumes no liability for any site visitor’s activities in connection with use of the Google Translate functionality or content.

    The Google Translate service is a means by which DoIT offers translations of content and is meant solely for the convenience of non-English speaking users of the website. The translated content is provided directly and dynamically by Google; DoIT has no direct control over the translated content as it appears using this tool. Therefore, in all contexts, the English content, as directly provided by DoIT is to be held authoritative.


    Ebola Virus Hemorrhagic Fever Fact Sheet

    PDF version of this Fact Sheet

    What is Ebola virus disease?

    Ebola virus disease (EVD) is a severe, often fatal, viral disease. Currently, there are EVD outbreaks in several Western African nations, including Guinea, Liberia, Sierra Leone and parts of Nigeria. For the most current information regarding EVD and outbreaks caused by EVD, visit http://www.cdc.gov/vhf/ebola/

    What are the symptoms of EVD?                                                                             

    EVD symptoms always include fever. Other symptoms may include headache, diarrhea, vomiting, weakness, joint and muscle aches, stomach pain, lack of appetite and bleeding. The symptoms can be similar to other, more common, infections. Symptoms appear 2-21 days after exposure to the virus, but most commonly occur 8-10 days after exposure.

    How is EVD spread?

    Individuals who do not have a fever are not contagious and cannot transmit the disease to another person. The Ebola virus is transmitted through direct contact with the blood or body fluids of an infected person with symptoms or through exposure to objects (such as needles) that have been contaminated with infected body fluids. Transmission can also occur from directly handling bats, rodents or primates in areas where EVD occurs.

    Who is at risk for EVD? 

    Individuals who have recently been in a country with known EVD, and who also have:
    • Contact with blood or other body fluids of a patient or dead body known to have or suspected to have EVD, or
    • Direct handling of bats, rodents or primates.
    If someone has symptoms of EVD and a possible exposure, that person should see a health care provider.

    What is the treatment for EVD?

    There is no specific treatment for EVD; treatment is limited to close monitoring and supportive care in a hospital.

    What is the risk of EVD in Maryland?

    Currently, the risk of acquiring EVD in Maryland is extremely low. As of August 11, 2014, there have been no confirmed cases in Maryland. If a case is identified, there are established infection control guidelines to prevent transmission.

    What is the Department of Health and Mental Hygiene (DHMH) doing?

    DHMH is monitoring the national and global situation and is in frequent communication with the Centers for Disease Control and Prevention (CDC). DHMH is conducting disease surveillance and regularly communicates with and distributes guidance to Maryland hospitals and health care providers. DHMH works with health care providers and local health departments to quickly investigate reports of possible EVD infections. 

    Where can I learn more?

    For more EVD information, visit: http://www.cdc.gov/vhf/ebola/.